BETA

BLUF is in public beta. Automated sourcing and summaries by the BLUF engine, monitored by our team. Summaries may contain errors — verify important details at the source. Not medical, legal or financial advice. Public beta — automated summaries may contain errors. Full disclaimer

BLUFSOURCED EVENT BRIEFLAST CHANGED
DRUGS, DEVICES & RECALLS • UNITED STATES

FDA says two lots of OsteoDenx capsules recalled over undeclared milk

1 OUTLET UNITED STATESONGOING
NOT MEDICAL ADVICE

This brief summarizes public reporting and official announcements. Research findings may be preliminary. Talk to a qualified clinician before making health decisions.

BLUF

bioQuad Life Sciences is recalling two lots of its OsteoDenx dietary supplement capsules because they contain undeclared milk, the FDA said. People with a milk allergy or severe sensitivity could face a serious or life-threatening reaction if they consume the product.

WHAT IS VERIFIED — AND WHAT IS NOT

Source coverage is not proof of every claim. Confirmed means direct support from an official record; corroborated means matching reporting; reported means attributed but not independently verified here. Disputed details remain unresolved.

CONFIRMED

bioQuad Life Sciences is recalling two lots of OsteoDenx dietary supplement capsules because they contain undeclared milk.

U.S. Food and Drug Administration
CONFIRMED

People with a milk allergy or severe sensitivity could have a serious or life-threatening allergic reaction if they consume the product.

U.S. Food and Drug Administration

HOW THIS BRIEF WAS MADE 1 outlet: 1 official. Automated sourcing and summaries by the BLUF engine. Corrections

CONFIDENCE: HIGH · SOURCE GRADE A2Coverage from 1 independent outlet; an official record (agency statement, filing or data) is among the sources. Coverage breadth does not verify every claim; see claim-level sources. What A2 means

Why it matters

The recall matters to people with milk allergies or severe sensitivities who may use the supplement.

What happens next

No next step or update time has been announced in the available reporting.

The rest of this brief is for BLUF readers with a plan
  • The full picture: every consequence, and the dates and decisions to watch
  • Timeline of how the story developed
  • How 1 outlets cover it, side by side (1 reports)
  • Claims and evidence: what's confirmed, reported or disputed
  • Background and Ask BLUF questions about this story

Plus gives you unlimited full stories for $8 a month. See plans Already have a plan? Sign in.